Tissue factor pathway inhibitor (TFPI) is a marker of tumor progression and prognosis in breast cancerM. Tinholt,H. K. M. Vollan,K. K. Sahlberg,R. Karesen,T. Sauer,V Kristensen,A-L Borresen-Dale,P. M. Sandset,N. IversenJOURNAL OF THROMBOSIS AND HAEMOSTASIS（2015）引用 0|浏览23AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
